Hologic (HOLX) Gets FDA Approval for Cervista HTA Used with HPV HR Test
Go back to Hologic (HOLX) Gets FDA Approval for Cervista HTA Used with HPV HR Test| Hologic, Inc. (NASDAQ: HOLX) | Delayed: 76.01 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $76.01 | 52 Week High | $41.66 | |||
| Open | $76.01 | 52 Week Low | $31.84 | |||
| Day High | $76.01 | P/E | N/A | |||
| Day Low | $76.01 | EPS | $-4.40 | |||
| Volume | 9,122 | |||||
